http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013010776-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 |
| filingDate | 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365dac8b39c023f17f1ad8e5c061fced http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_343da6b897aa58345586d6f2686bc117 |
| publicationDate | 2013-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013010776-A |
| titleOfInvention | Spinal cerebellar degeneration treatment |
| abstract | [PROBLEMS] To provide spinal cerebellar degeneration (spinocerebellar ataxia or atrophy, degeneration) including a neurodegenerative disease having a lesion in the nucleus or conduction pathway from the cerebellum or brainstem to the spinal cord, a therapeutic agent for multiple system atrophy, or ataxia Alternatively, provide an agent for improving balance disorder. [Solution] Wherein R is methyl, all possible isomers and racemates, pharmaceutically acceptable salts thereof, or solvates thereof. [Selection figure] None |
| priorityDate | 2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.